Biophytis S.A. (EPA:ALBPS)
France · Delayed Price · Currency is EUR 0.0400
+0.0336 (525.00%)
Aug 3, 2026, 5:35 PM CET
Biophytis Market Cap
Biophytis has a market cap or net worth of €586.38 thousand as of August 3, 2026. Its market cap has decreased by -85.97% in one year.
Market Cap
586.38K
Enterprise Value
7.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.04
ChartMarket Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 45.17M to 586.38K, a decrease of -98.70%. That is a compound annual growth rate of -32.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 586.38K | -62.09% |
| Dec 31, 2025 | 1.55M | -44.45% |
| Dec 31, 2024 | 2.78M | -23.40% |
| Dec 29, 2023 | 3.64M | -51.74% |
| Dec 30, 2022 | 7.53M | -87.89% |
| Dec 31, 2021 | 62.22M | -32.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |
| Poxel | 11.26M |
| NFL Biosciences | 11.02M |
| Aton | 8.45M |
| Oncodesign Precision Medicine Société anonyme | 6.13M |
| TME Pharma | 5.89M |
| Plant Advanced Technologies | 5.51M |